Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Unger

Showing results (41-50 of 239) with videos related to

Pageof 24
Sort By:
Pharmacological Research|July 12, 2017
AT2 receptors in cardiovascular and renal diseasesElena Kaschina, Pawel Namsolleck, Thomas Unger
Pain|March 1, 2005
Excitatory and modulatory effects of inflammatory cytokines and neurotrophins on mechanosensitive group IV muscle afferents in the ratUlrich Hoheisel, Thomas Unger, Siegfried Mense
Heart Failure Monitor|July 9, 2008
The pharmacological rationale behind polypharmacy in heart failureKai Kappert, Heike Kusserow, Thomas Unger
Expert Review of Cardiovascular Therapy|November 4, 2006
Effective treatment of hypertension by AT(1) receptor antagonism: the past and future of telmisartanMatthias Goebel, Markus Clemenz, Thomas Unger
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 10, 2009
Introduction: Reducing cardiovascular risk: ONTARGET--a new standard in cardiovascular protectionGiuseppe Mancia, Thomas Unger, Alberto Zanchetti
Pain|September 13, 2005
The possible role of the NO-cGMP pathway in nociception: different spinal and supraspinal action of enzyme blockers on rat dorsal horn neuronesUlrich Hoheisel, Thomas Unger, Siegfried Mense
Journal of Hypertension|March 2, 2006
The metabolic syndrome: cluster with a self-fulfilling loop?Markus Clemenz, Ulrich Kintscher, Thomas Unger
Brain Research|August 19, 2007
Sensitization of rat dorsal horn neurons by NGF-induced subthreshold potentials and low-frequency activation. A study employing intracellular recordings in vivoUlrich Hoheisel, Thomas Unger, Siegfried Mense
Nature Reviews. Cardiology|March 21, 2012
Key advances in antihypertensive treatmentLudovit Paulis, Ulrike M Steckelings, Thomas Unger
Nature|February 1, 2013
Perspective: A tale of two receptorsSébastien Foulquier, Ulrike Muscha Steckelings, Thomas Unger
Pageof 24

Showing results (41-50 of 239) with videos related to

Sort By:
Pageof 24
Pharmacological Research|July 12, 2017
AT2 receptors in cardiovascular and renal diseasesElena Kaschina, Pawel Namsolleck, Thomas Unger
Pain|March 1, 2005
Excitatory and modulatory effects of inflammatory cytokines and neurotrophins on mechanosensitive group IV muscle afferents in the ratUlrich Hoheisel, Thomas Unger, Siegfried Mense
Heart Failure Monitor|July 9, 2008
The pharmacological rationale behind polypharmacy in heart failureKai Kappert, Heike Kusserow, Thomas Unger
Expert Review of Cardiovascular Therapy|November 4, 2006
Effective treatment of hypertension by AT(1) receptor antagonism: the past and future of telmisartanMatthias Goebel, Markus Clemenz, Thomas Unger
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 10, 2009
Introduction: Reducing cardiovascular risk: ONTARGET--a new standard in cardiovascular protectionGiuseppe Mancia, Thomas Unger, Alberto Zanchetti
Pain|September 13, 2005
The possible role of the NO-cGMP pathway in nociception: different spinal and supraspinal action of enzyme blockers on rat dorsal horn neuronesUlrich Hoheisel, Thomas Unger, Siegfried Mense
Journal of Hypertension|March 2, 2006
The metabolic syndrome: cluster with a self-fulfilling loop?Markus Clemenz, Ulrich Kintscher, Thomas Unger
Brain Research|August 19, 2007
Sensitization of rat dorsal horn neurons by NGF-induced subthreshold potentials and low-frequency activation. A study employing intracellular recordings in vivoUlrich Hoheisel, Thomas Unger, Siegfried Mense
Nature Reviews. Cardiology|March 21, 2012
Key advances in antihypertensive treatmentLudovit Paulis, Ulrike M Steckelings, Thomas Unger
Nature|February 1, 2013
Perspective: A tale of two receptorsSébastien Foulquier, Ulrike Muscha Steckelings, Thomas Unger
Pageof 24